AAAAAA

   
Results: 1-7 |
Results: 7
Novel synthesis of unsymmetrical azines from semicarbazones and aldehydes
Authors: Ren, ZJ Cao, WG Tong, WQ Xi, JJ
Citation: Zj. Ren et al., Novel synthesis of unsymmetrical azines from semicarbazones and aldehydes, SYN COMMUN, 31(1), 2001, pp. 125-129
Effects of fenofibrate on lipid parameters in obese rhesus monkeys
Authors: Winegar, DA Brown, PJ Wilkison, WO Lewis, MC Ott, RJ Tong, WQ Brown, HR Lehmann, JM Kliewer, SA Plunket, KD Way, JM Bodkin, NL Hansen, BC
Citation: Da. Winegar et al., Effects of fenofibrate on lipid parameters in obese rhesus monkeys, J LIPID RES, 42(10), 2001, pp. 1543-1551
Studies on the reaction of 1,2,3-trisubstituted electron-deficient cyclopropane derivatives with methanol
Authors: Cao, WG Ding, WY Tong, WQ Liu, X Qiu, MY
Citation: Wg. Cao et al., Studies on the reaction of 1,2,3-trisubstituted electron-deficient cyclopropane derivatives with methanol, CHEM J CH U, 21(5), 2000, pp. 740-742
Studies on stereoselective synthetic methods of 2,3,4,5-tetrasubstituted-cis-2,3-dihydrofurans
Authors: Ding, WY Tong, WQ Zhai, YA Cai, ZR
Citation: Wy. Ding et al., Studies on stereoselective synthetic methods of 2,3,4,5-tetrasubstituted-cis-2,3-dihydrofurans, CHEM J CH U, 20(1), 1999, pp. 64-67
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat
Authors: Brown, KK Henke, BR Blanchard, SG Cobb, JE Mook, R Kaldor, I Kliewer, SA Lehmann, JM Lenhard, JM Harrington, WW Novak, PJ Faison, W Binz, JG Hashim, MA Oliver, WO Brown, HR Parks, DJ Plunket, KD Tong, WQ Menius, JA Adkison, K Noble, SA Willson, TM
Citation: Kk. Brown et al., A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat, DIABETES, 48(7), 1999, pp. 1415-1424
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
Authors: Collins, JL Blanchard, SG Boswell, GE Charifson, PS Cobb, JE Henke, BR Hull-Ryde, EA Kazmierski, WM Lake, DH Leesnitzer, LM Lehmann, J Lenhard, JM Orband-Miller, LA Gray-Nunez, Y Parks, DJ Plunkett, KD Tong, WQ
Citation: Jl. Collins et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety, J MED CHEM, 41(25), 1998, pp. 5037-5054
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
Authors: Cobb, JE Blanchard, SG Boswell, EG Brown, KK Charifson, PS Cooper, JP Collins, JL Dezube, M Henke, BR Hull-Ryde, EA Lake, DH Lenhard, JM Oliver, W Oplinger, J Pentti, M Parks, DJ Plunket, KD Tong, WQ
Citation: Je. Cobb et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent, J MED CHEM, 41(25), 1998, pp. 5055-5069
Risultati: 1-7 |